UroGen Pharma Ltd. - Ordinary Shares (URGN): Price and Financial Metrics
URGN Price/Volume Stats
| Current price | $11.06 | 52-week high | $20.70 |
| Prev. close | $11.20 | 52-week low | $9.03 |
| Day low | $10.59 | Volume | 602,800 |
| Day high | $11.16 | Avg. volume | 385,447 |
| 50-day MA | $10.67 | Dividend yield | N/A |
| 200-day MA | $12.79 | Market Cap | 509.80M |
URGN Stock Price Chart Interactive Chart >
UroGen Pharma Ltd. - Ordinary Shares (URGN) Company Bio
UroGen Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing therapies for urological pathologies. The company is developing its product candidates as chemoablation agents, which are designed to remove tumors by non-surgical means, to treat several forms of non-muscle invasive urothelial cancer, including low-grade upper tract urothelial carcinoma, and low-grade bladder cancer. The company was founded in 2004 and is based in Raanana, Israel.
URGN Price Returns
| 1-mo | 16.91% |
| 3-mo | N/A |
| 6-mo | -10.66% |
| 1-year | -22.11% |
| 3-year | 26.54% |
| 5-year | -34.94% |
| YTD | 3.85% |
| 2024 | -29.00% |
| 2023 | 69.11% |
| 2022 | -6.73% |
| 2021 | -47.23% |
| 2020 | -46.00% |
Loading social stream, please wait...